Literature DB >> 18419536

Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women.

C J Gill1, V Mwanakasale, M P Fox, R Chilengi, M Tembo, M Nsofwa, V Chalwe, L Mwananyanda, D Mukwamataba, B Malilwe, D Champo, W B Macleod, D M Thea, D H Hamer.   

Abstract

Nasopharyngeal colonization with Streptococcus pneumoniae precedes invasive pneumococcal disease. Human immunodeficiency virus (HIV) infection increases rates of invasive pneumococcal disease, and its effect on colonization is unknown. In a longitudinal cohort of Zambian mothers with or without HIV infection, HIV infection increased the risk of colonization (risk ratio [RR], 1.9; 95% confidence interval [CI], 1.3-2.8) and repeat colonization (RR, 2.4; 95% CI, 1.1-5.3) and reduced the time to new colonization (P = .01). Repeat colonization with homologous sero/factor types occurred only among HIV-positive mothers. Pediatric serotypes 6, 19, and 23 accounted for excess colonization among HIV-positive mothers. HIV infection significantly increases the risk of pneumococcal colonization. Increased rates of colonization by pediatric serotypes suggest a potential role for the 7-valent pneumococcal vaccine in HIV-infected adults.

Entities:  

Mesh:

Year:  2008        PMID: 18419536      PMCID: PMC3869545          DOI: 10.1086/528806

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Nasopharyngeal colonization with Streptococcus pneumoniae in children infected with human immunodeficiency virus.

Authors:  Viviane C Cardoso; Maria C Cervi; Otávio A L Cintra; Adriana S M Salathiel; Ana C L F Gomes
Journal:  J Pediatr (Rio J)       Date:  2006 Jan-Feb       Impact factor: 2.197

2.  Rapid HIV testing and counseling for voluntary testing centers in Africa.

Authors:  S L McKenna; G K Muyinda; D Roth; M Mwali; N Ng'andu; A Myrick; C Luo; F H Priddy; V M Hall; A A von Lieven; J R Sabatino; K Mark; S A Allen
Journal:  AIDS       Date:  1997-09       Impact factor: 4.177

3.  Invasive pneumococcal disease: clinical features, serotypes, and antimicrobial resistance patterns in cases involving patients with and without human immunodeficiency virus infection.

Authors:  R E Frankel; M Virata; C Hardalo; F L Altice; G Friedland
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

4.  Oropharyngeal colonization by Streptococcus pneumoniae among HIV-infected adults in Uganda: assessing prevalence and antimicrobial susceptibility.

Authors:  David B Blossom; Grace Namayanja-Kaye; Joan Nankya-Mutyoba; John B Mukasa; Henry Bakka; Sandra Rwambuya; Anne Windau; Saralee Bajaksouzian; Courtney J Walker; Moses L Joloba; Cissy Kityo; Peter Mugyenyi; Christopher C Whalen; Michael R Jacobs; Robert A Salata
Journal:  Int J Infect Dis       Date:  2006-09-25       Impact factor: 3.623

5.  Streptococcus pneumoniae blood culture isolates from patients with and without human immunodeficiency virus infection: alterations in penicillin susceptibilities and in serogroups or serotypes.

Authors:  H H Crewe-Brown; A S Karstaedt; G L Saunders; M Khoosal; N Jones; A Wasas; K P Klugman
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

6.  Prevalence, serotypes, and risk factors for pneumococcal carriage among HIV-infected adults.

Authors:  Christiane Nicoletti; M Cristina C Brandileone; M Luiza S Guerra; Anna S Levin
Journal:  Diagn Microbiol Infect Dis       Date:  2007-02-09       Impact factor: 2.803

7.  Antibodies against pneumococcal polysaccharides after vaccination in HIV-infected individuals: 5-year follow-up of antibody concentrations.

Authors:  F P Kroon; J T van Dissel; E Ravensbergen; P H Nibbering; R van Furth
Journal:  Vaccine       Date:  1999-10-14       Impact factor: 3.641

8.  The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population.

Authors:  N Jones; R Huebner; M Khoosal; H Crewe-Brown; K Klugman
Journal:  AIDS       Date:  1998-11-12       Impact factor: 4.177

9.  Clinical and epidemiologic studies of pneumococcal infection in children.

Authors:  B M Gray; H C Dillon
Journal:  Pediatr Infect Dis       Date:  1986 Mar-Apr

10.  Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya.

Authors:  C F Gilks; S A Ojoo; J C Ojoo; R J Brindle; J Paul; B I Batchelor; J N Kimari; R Newnham; J Bwayo; F A Plummer
Journal:  Lancet       Date:  1996-03-16       Impact factor: 79.321

View more
  21 in total

1.  Genomic load from sputum samples and nasopharyngeal swabs for diagnosis of pneumococcal pneumonia in HIV-infected adults.

Authors:  Werner C Albrich; Shabir A Madhi; Peter V Adrian; Jean-Noel Telles; Glaucia Paranhos-Baccalà; Keith P Klugman
Journal:  J Clin Microbiol       Date:  2014-09-24       Impact factor: 5.948

2.  Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization.

Authors:  Shabir A Madhi; Avy Violari; Keith P Klugman; Gina Lin; James A McIntyre; Anne von Gottberg; Patrick Jean-Philippe; Mark F Cotton; Peter Adrian
Journal:  Vaccine       Date:  2011-07-23       Impact factor: 3.641

Review 3.  Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development.

Authors:  Richard Malley
Journal:  J Mol Med (Berl)       Date:  2010-01-05       Impact factor: 4.599

4.  The alveolar microenvironment of patients infected with human immunodeficiency virus does not modify alveolar macrophage interactions with Streptococcus pneumoniae.

Authors:  Stephen B Gordon; R Thomas Jagoe; Elizabeth R Jarman; James C North; Alison Pridmore; Janelisa Musaya; Neil French; Eduard E Zijlstra; Malcolm E Molyneux; Robert C Read
Journal:  Clin Vaccine Immunol       Date:  2013-04-10

5.  High rate of pneumococcal bacteremia in a prospective cohort of older children and adults in an area of high HIV prevalence in rural western Kenya.

Authors:  Daniel R Feikin; Geoffrey Jagero; Barrack Aura; Godfrey M Bigogo; Joseph Oundo; Bernard W Beall; Angela Karani; Susan Morpeth; M Kariuki Njenga; Robert F Breiman
Journal:  BMC Infect Dis       Date:  2010-06-23       Impact factor: 3.090

6.  Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi.

Authors:  Dean B Everett; Mavuto Mukaka; Brigitte Denis; Stephen B Gordon; Enitan D Carrol; Joep J van Oosterhout; Elizabeth M Molyneux; Malcolm Molyneux; Neil French; Robert S Heyderman
Journal:  PLoS One       Date:  2011-03-15       Impact factor: 3.240

7.  Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal.

Authors:  Jo Seddon; Sanjay Bhagani
Journal:  HIV AIDS (Auckl)       Date:  2011-04-04

8.  Direct ex-vivo evaluation of pneumococcal specific T-cells in healthy adults.

Authors:  Aamir Aslam; Helen Chapel; Graham Ogg
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

9.  Evaluation of urine pneumococcal antigen test performance among adults in Western Kenya.

Authors:  Lee M Hampton; Godfrey Bigogo; Geofrey Jagero; Maria da Gloria Carvalho; Fabiana Pimenta; Muthoni Junghae; Robert F Breiman; Cynthia G Whitney; Daniel R Feikin; Laura M Conklin
Journal:  Diagn Microbiol Infect Dis       Date:  2016-05-06       Impact factor: 2.803

10.  Increased IgG but normal IgA anti-pneumococcal protein antibodies in lung of HIV-infected adults.

Authors:  Andrea M Collins; Sherouk El Batrawy; Stephen B Gordon; Daniela M Ferreira
Journal:  Vaccine       Date:  2013-05-10       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.